Ireland vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Access to anti-retroviral drugs, male

Ireland
89.0%
in 2023
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
22.9%
in 2024
Ireland rank
17th
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank
18th

Access to anti-retroviral drugs, male over time

  • Ireland
  • Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
020406080200020122024

How they compare

Ireland currently reports 89.0% against 22.9% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 66.1%.

That makes Ireland's figure about 3.9 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.

Across all 24 years both countries report, Ireland has been ahead every year.

Ireland ranks 17th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th of 141 countries.

Ireland has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Ireland Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) Difference Ahead
2000s 47.1% 3.3% 43.8% Ireland
2010s 71.4% 10.3% 61.1% Ireland
2020s 87.5% 18.5% 69.0% Ireland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, male, Ireland or Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
Ireland, at 89.0% against 22.9% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2023.
What is the difference in access to anti-retroviral drugs, male between Ireland and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
66.1%, with Ireland ahead.
How many years of comparable data are there for Ireland and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)?
24 years are reported by both, from 2000 to 2023.
How do Ireland and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) rank globally for access to anti-retroviral drugs, male?
Ireland ranks 17th and Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 18th of 141 countries.
Where does this data come from?
UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Ireland vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Access to anti-retroviral drugs, male. Statizoid, drawing on UNAIDS estimates. Retrieved 19 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-male-percent/ireland/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-male-percent/ireland/middle-east-north-africa-afghanistan-and-pakistan-ida-and-ibrd/">Ireland vs Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD): Access to anti-retroviral drugs, male</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.